Clinical trial DECRESCENDO
De-Escalation of adjuvant ChemotheRapy in HER2-positive, EStrogen reCEptor-negative, Node-negative early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and Dual HER2 blOckade
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | Institut Jules Bordet |
EudraCT Identifier | 2020-002918-41 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04675827 |
Last update |